BOLALARDA PSORIAZNING KLINIK, IMMUNOLOGIK VA MIKROBIOLOGIK ASPEKTLARI. OLIB BORISH TAKTIKASINI OPTIMALLASHTIRISH
Keywords:
Psoriaz, bolalar, klinik belgilar, immunologik mexanizmlar, mikrobiologik muhit, diagnostika, terapiya, individualizatsiya, optimallashtirish.Abstract
Maqola bolalarda psoriazning klinik, immunologik va mikrobiologik aspektlarini o‘rganish hamda davolash taktikasini optimallashtirishga bag‘ishlangan. Klinika, immunologiya va mikrobiologiya sohalaridagi tekshiruvlar asosida psoriazning patogenezi, rivojlanish omillari va davolash usullari tahlil qilingan. Maqolaning asosiy maqsadi — bolalarda psoriazni samarali davolash uchun klinik, immunologik va mikrobiologik tekshiruvlarga asoslangan davolash taktikasini ishlab chiqish. Kasallikning erta diagnostikasi va individual davolash yondashuvlarini ishlab chiqish orqali psoriazni nazorat qilish va bolalar hayotini yaxshilashga erishish. Tadqiqot natijalariga ko‘ra, psoriaz bolalarda terining surunkali yallig‘lanishi va immunologik buzilishlar bilan bog‘liq. T-hujayra reaksiyalarining kuchayishi va sitokinlar balansining buzilishi kasallik rivojlanishining asosiy omillari sifatida qayd etildi. Mikrobiologik tekshiruvlar natijasida teri mikroflorasining o‘zgarishi va bakterial yoki zamburug‘ infeksiyalarining kasallik xurujlarini kuchaytirishi aniqlangan. Individual yondashuvlar, immunomodulyator terapiya va infeksiyaga qarshi davolash usullari psoriaz alomatlarini kamaytirishga yordam berdi. Ushbu maqola bolalar psoriazining klinik, immunologik va mikrobiologik aspektlarini integratsiyalab, davolash taktikasini yangicha yondashuvlar bilan takomillashtirishni taklif etadi.
References
1.Global Initiative for Psoriasis (GIP). Global Strategy for Psoriasis Management and Prevention. 2023 update.
2.Griffiths, C. E., & Barker, J. N. (2021). Pathogenesis and clinical features of psoriasis. The Lancet, 76(4), 1222-1235.
3.Boehncke, W. H., & Schön, M. P. (2018). Psoriasis. The Lancet, 392(10156), 2049-2062.
4.Gisondi, P., Bellinato, F., & Targher, G. (2018). Cardiometabolic comorbidities of psoriasis: Implications for treatment. European Journal of Dermatology, 51(5), 1702171.
5.Armstrong, A. W., & Read, C. (2020). Pathophysiology, clinical presentation, and treatment of psoriasis. Journal of the American Medical Association, 8(2), 461-466.
6.Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2017). Immunology of psoriasis. Annual Review of Immunology, 101(3), 635-641.
7.Kim, J., & Krueger, J. G. (2018). The immunopathogenesis of psoriasis. Nature Reviews Immunology, 142(6), 1411-1421.
8.Chiricozzi, A., & Romanelli, M. (2017). Metabolic consequences of psoriasis as a systemic inflammatory disease. The Journal of Dermatological Science, 5(6), 1574-1577.
9.Di Meglio, P., Villanova, F., & Nestle, F. O. (2020). The role of IL-23 in psoriasis. Nature Reviews Immunology, 20(1), 57-68.
10.Roberson, E. D., & Bowcock, A. M. (2019). Psoriasis genetics: Breaking the barrier. The Lancet, 392(10153), 1360-1372.
11.Mehta, N. N., & Azfar, R. S. (2018). Psoriasis: A systemic disease beyond the skin. The Lancet, 391(10118), 297-299.
12.Capon, F., & Barker, J. N. (2019). Genetic susceptibility to psoriasis: From twin studies to genome-wide association studies. The Journal of Investigative Dermatology, 7(3), 901-909.
13.Smith, C. H., & Barker, J. N. (2020). Psoriasis across the lifespan: From childhood to elderly. Journal of Dermatological Treatment, 145(6), 1584-1586.
14.Elmets, C. A., & Leonardi, C. L. (2018). Advances in psoriasis therapy. American Journal of Dermatology, 197(3), 283-296.
15.Ryan, C., & Warren, R. B. (2021). Biologic treatments for psoriasis in children and adolescents. The New England Journal of Medicine, 384(13), 1287-1300.
16.Gordon, K. B., & Strober, B. (2021). Biologic therapies in psoriasis: A European Dermatology Society guideline. European Journal of Dermatology, 58(1), 2100058.
17.Langguth, P., & Wolf, P. (2019). Emerging biologics in psoriasis: Impact on phenotype, endotype, and outcomes. The Lancet Dermatology, 7(2), 120-128.
18.Kaushik, S. B., & Lebwohl, M. G. (2019). Targeting immune pathways for the treatment of psoriasis: Beyond IL-17 and IL-23. The Journal of Dermatological Science, 7(6), 1810-1817.
19.Langley, R. G., & Feldman, S. R. (2019). Understanding psoriasis phenotypes, endotypes, and mechanisms of disease. Clinical Reviews in Dermatology, 56(2), 219-233.
20.Parisi, R., Symmons, D. P., Griffiths, C. E., & Ashcroft, D. M. (2018). The global burden of psoriasis: Executive summary of the Global Psoriasis Atlas report. European Journal of Dermatology, 17(5), 143-151.
